NJHA Releases New Opioid Educational Blueprint

Document is the latest in a series of steps to make distribution safer

The New Jersey Hospital Association (NJHA) has released a new educational blueprint for healthcare providers involved in the treatment of patients with ongoing pain. The blueprint is part of an initiative to increase awareness and curb the opioid addiction problem across the state.

Former governor Chris Christie was especially influential in urging Congress and others to take steps towards greater education surrounding opioid-based medications.

The new blueprint’s stated purpose is to ensure that the benefits of opioid analgesics outweigh the risks. The Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) was approved by the FDA back in 2012, and is currently undergoing modification.

The new guidelines will require that all opioid analgesic companies must provide education for healthcare providers who participate in the treatment and monitoring of pain. This will include not only prescribers themselves, but other personnel such as pharmacists and nurses.

The education will be offered through ongoing continuing education activities.

Healthcare providers will also receive literature and other useful materials for counseling patients about the misuse of opioid-based medications.

The full blueprint is available here.

About The Author